See more : Ault Disruptive Technologies Corporation (ADRT) Income Statement Analysis – Financial Results
Complete financial analysis of Avivagen Inc. (VIV.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avivagen Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Geiger Counter Limited (GCL.L) Income Statement Analysis – Financial Results
- Bass Oil Limited (BAS.AX) Income Statement Analysis – Financial Results
- Princeton Technology Corporation (6129.TWO) Income Statement Analysis – Financial Results
- Al Khaleej Training and Education Company (4290.SR) Income Statement Analysis – Financial Results
- Hefei Metalforming Intelligent Manufacturing Co., Ltd. (603011.SS) Income Statement Analysis – Financial Results
Avivagen Inc. (VIV.V)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.avivagen.com
About Avivagen Inc.
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 939.17K | 1.30M | 1.18M | 977.45K | 1.07M | 255.66K | 161.19K | 163.97K | 295.67K | 110.52K | 417.56K | 289.31K | 184.54K | 1.18M | 412.25K | 359.05K | 54.71K |
| Cost of Revenue | 538.87K | 761.65K | 706.88K | 450.97K | 418.84K | 83.18K | 2.44K | 1.11K | 55.56K | 4.36K | 112.53K | 32.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 400.30K | 534.34K | 470.98K | 526.48K | 653.74K | 172.48K | 158.75K | 162.85K | 240.11K | 106.16K | 305.04K | 257.19K | 184.54K | 1.18M | 412.25K | 359.05K | 54.71K |
| Gross Profit Ratio | 42.62% | 41.23% | 39.99% | 53.86% | 60.95% | 67.46% | 98.48% | 99.32% | 81.21% | 96.05% | 73.05% | 88.90% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 640.62K | 534.98K | 825.19K | 795.21K | 551.17K | 587.38K | 376.44K | 850.86K | 976.53K | 1.49M | 1.39M | 1.05M | 862.62K | 395.19K |
| General & Administrative | 1.90M | 4.69M | 4.33M | 3.77M | 4.27M | 4.16M | 1.94M | 1.47M | 1.62M | 1.98M | 1.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 108.74K | 95.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.90M | 4.69M | 4.33M | 3.77M | 4.27M | 4.16M | 1.94M | 1.58M | 1.71M | 1.98M | 1.31M | 2.12M | 1.29M | 1.09M | 668.92K | 507.81K | 477.99K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.19K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.93M | 4.64M | 3.86M | 4.42M | 4.80M | 5.01M | 2.77M | 2.17M | 2.34M | 2.43M | 2.25M | 3.22M | 2.82M | 2.49M | 1.72M | 1.37M | 873.17K |
| Cost & Expenses | 2.47M | 5.40M | 4.56M | 4.87M | 5.22M | 5.09M | 2.77M | 2.17M | 2.39M | 2.43M | 2.36M | 3.25M | 2.82M | 2.49M | 1.72M | 1.37M | 873.17K |
| Interest Income | 680.00 | 4.69K | 9.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.77M | 1.59M | 1.22M | 726.06K | 299.18K | 211.72K | 143.66K | 0.00 | -5.36K | 10.58K | 19.94K | 22.21K | 131.47K | 65.20K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 87.50K | 124.77K | 127.49K | 4.64K | 2.54K | 52.52K | 11.73K | 20.82K | 33.10K | 68.17K | 88.36K | 195.26K | 97.86K | 62.70K | 70.57K | 32.23K | 6.39K |
| EBITDA | -846.03K | -4.68M | -3.41M | -4.11M | -4.53M | -4.83M | -2.60M | -1.99M | -2.06M | -2.25M | -1.86M | -2.77M | -2.54M | -1.24M | -1.24M | -979.15K | -812.07K |
| EBITDA Ratio | -90.08% | -361.37% | -289.39% | -420.04% | -422.57% | -1,890.76% | -1,611.21% | -1,212.48% | -697.44% | -2,037.36% | -444.54% | -957.06% | -1,377.69% | -104.85% | -300.24% | -272.70% | -1,484.29% |
| Operating Income | -933.53K | -4.81M | -3.54M | -4.11M | -4.53M | -4.83M | -2.61M | -2.00M | -2.08M | -2.02M | -1.97M | -3.47M | -2.64M | -1.30M | -1.31M | -1.01M | -818.46K |
| Operating Income Ratio | -99.40% | -371.00% | -300.21% | -420.52% | -422.80% | -1,890.76% | -1,618.48% | -1,222.18% | -703.62% | -1,831.41% | -472.61% | -1,199.50% | -1,430.72% | -110.15% | -317.36% | -281.68% | -1,495.98% |
| Total Other Income/Expenses | -5.13M | -2.12M | -766.58K | -872.76K | -510.99K | -211.72K | -133.76K | 0.00 | 0.00 | 0.00 | -312.00 | -39.56K | -138.95K | 24.19K | 39.36K | -26.68K | 5.95K |
| Income Before Tax | -6.07M | -6.39M | -4.75M | -4.84M | -4.83M | -5.05M | -2.75M | -2.00M | -2.08M | -2.02M | -1.97M | -3.51M | -2.78M | -1.28M | -1.27M | -1.04M | -812.52K |
| Income Before Tax Ratio | -645.91% | -493.38% | -403.38% | -494.80% | -450.70% | -1,973.58% | -1,707.61% | -1,222.18% | -703.62% | -1,831.41% | -472.69% | -1,213.17% | -1,506.02% | -108.10% | -307.81% | -289.11% | -1,485.11% |
| Income Tax Expense | 1.77M | 1.55M | 1.19M | 676.06K | 49.18K | 90.02K | 0.00 | -4.92K | -5.36K | 10.58K | 19.94K | 22.21K | 131.47K | 65.20K | 0.00 | 0.00 | 0.00 |
| Net Income | -6.07M | -6.39M | -4.75M | -4.84M | -4.83M | -5.14M | -2.75M | -2.00M | -2.08M | -2.02M | -1.97M | -3.51M | -2.78M | -1.34M | -1.27M | -1.04M | -812.52K |
| Net Income Ratio | -645.91% | -493.38% | -403.38% | -494.80% | -450.70% | -2,008.79% | -1,707.61% | -1,222.18% | -703.62% | -1,831.41% | -472.69% | -1,213.17% | -1,506.02% | -113.61% | -307.81% | -289.11% | -1,485.11% |
| EPS | -0.09 | -0.12 | -0.12 | -0.14 | -0.15 | -0.18 | -0.12 | -0.10 | -0.12 | -0.18 | -0.24 | -0.66 | -0.81 | -0.60 | -0.57 | -0.50 | -0.46 |
| EPS Diluted | -0.09 | -0.12 | -0.12 | -0.14 | -0.15 | -0.18 | -0.12 | -0.10 | -0.12 | -0.18 | -0.24 | -0.66 | -0.81 | -0.60 | -0.57 | -0.50 | -0.46 |
| Weighted Avg Shares Out | 66.03M | 52.44M | 40.31M | 34.36M | 33.06M | 29.03M | 22.36M | 19.34M | 16.90M | 11.31M | 8.34M | 5.35M | 3.45M | 2.25M | 2.23M | 2.10M | 1.78M |
| Weighted Avg Shares Out (Dil) | 66.03M | 52.44M | 40.31M | 34.36M | 33.06M | 29.03M | 22.36M | 19.34M | 16.90M | 11.31M | 8.34M | 5.35M | 3.45M | 2.25M | 2.23M | 2.10M | 1.78M |
Source: https://incomestatements.info
Category: Stock Reports